|Generate QR code
Open Access
Subscription Access
Structural and Spectroscopic Characterization of 3-[4-(Trifluoromethyl)Phenyl]-3a,4,8,8a-Tetrahydro-6H-[1,3]Dioxepino[5,6-d][1,2]Oxazole Compound: an Experimental and Density Functional Theory Study
Abstract
To better understand the molecular definition of 3-[4-(trifluoromethyl)phenyl]-3a,4,8,8a-tetrahydro6H-[1,3]dioxepino[5,6-d][1,2]oxazole (OXE-OXA) compound, we examined its molecular geometric structure and spectroscopic properties in detail. First, we determined the OXE-OXA compound’s crystal structure using single-crystal X-ray diffraction data, then we grew a single crystal of the OXE-OXA compound using the slow evaporation solution magnification technique at room temperature with ethanol. It was found that the OXE-OXA compound crystallizes in the monoclinic crystal system with the noncentrosymmetric space group P 1 21/n 1. We performed the theoretical calculations for OXE-OXA compound at the B3LYP/6- 311++G(d,p) and HSEh1PBE/6-311++G(d,p) levels of the density functional theory method. According to the comparison of our obtained data, the experimental 1H and 13C nuclear magnetic resonance chemical shifts were in strong agreement with the values for simulated chemical shifts. Later, we investigated the experimental FT-IR and theoretical IR spectrum of OXE-OXA compounds in the 4000–400 cm–1 region.
About the Authors
H. Gümüş
Golcuk Vocational School at Kocaeli University
Turkey
Turkey
Kocaeli
N. Tekin
Kocaeli University
Russian Federation
Russian Federation
Department of Chemistry, Science and Art Faculty,
Umuttepe, Kocaeli
Y. S. Kara
Kocaeli University
Russian Federation
Russian Federation
Department of Chemistry, Science and Art Faculty,
Umuttepe, Kocaeli
References
1. B. Prugoveki, M. Marinkovi, M. Vinkovi, M. Dumi, Croatica Chem. Acta C, 79, 219–226 (2006).
2. W. Gul, P. Carvalho, A. Galal, M. A. Averyb, M. A. El Sohly, Acta Cryst., 65, 358–359 (2009).
3. D. Palla, A. I. Antoniou, M. Baltas, C. Menendez, P. Grellier, E. Mouray, C. M. Athanassopoulos, Molecules, 25, 4858 (2020).
4. C. H. Lakshmi Praveena, V. Esther Rani, Y. N. Spoorthy, L. K. Ravindranath, J. Chem. Pharm. Res., 5, 280–292 (2013).
5. R. S. Pavelyev, R. M. Vafina, K. V. Balakin, O. I. Gnezdilov, A. B. Dobrynin, O. A. Lodochnikova, R. Z. Musin, G. A. Chmutova, S. A. Lisovskaya, L. E. Nikitina, Hindawi J. Chem., 14, 3589342 (2018).
6. E. Rani, M. Rani, L. K. Ravindranath, J. Med. Org. Chem., 3, 11–20 (2016).
7. S. Jana, S. Iram, J. Thomas, M. Q. Hayat, C. Pannecouque, W. Dehaen, Molecules, 22, 303 (2017).
8. H. Deng, X. Huang, C. Jin, C. M. Jin, Z. S. Quan, Bioorg. Chem., 94, 103467 (2020).
9. N. T. Giang, D. T. Tuyet Anh, H. T. Phuong, N. Thanh, N. Tuyen, Vietnam J. Chem., 56, 167–171 (2018).
10. K. V. Chikkula, S. Raja, Int. J. Pharm. Pharm. Sci., 9, 13–24 (2017).
11. A. Shaik, R. R. Bhandare, K. Palleapati, S. Nissankararao, V. Kancharlapalli, Shahanaaz Shaik, Molecules, 25, 1047 (2020).
12. A. Banerjee, S. Bandyopadhyay, A. Gayen, T. Sengupta, A. Das, G. K. Chatterjee, S. K. Chaudhuri, Arzneimittel for Schung, 44, 863–866 (1994).
13. K. V. Chikkula, R. Sundararajan, Med. Chem. Res., 26, 3026–3037 (2017).
14. R. Chaithra, S. Kumar, T. Pramila, D. N. Vidya, EJPMR, 6, 274–281 (2019).
15. Y. Kara, S. Yalduz, J. Mol. Struct., 1193, 158–165 (2019).
16. APEX2, version 2014.11-0, Bruker (2014) Bruker AXS Inc., Madison
17. SAINT, version 8.34A, Bruker (2013) Bruker AXS Inc., Madison
18. SADABS, version2014/5, Bruker (2014) Bruker AXS Inc., Madison
19. G. M. Sheldrick, Acta Crystallogr. A, A71, 3 (2015).
20. G. M. Sheldrick, Acta Crystallogr. C, C71, 3 (2015).
21. O. V. Dolomanov, L. Bourhis, R. J. Gildea, A. K. Howard, H. Puschmann, J. Appl. Cryst. 42, 339–341 (2009).
22. A. L. Spek, J. Appl. Cryst., 36, 7–11 (2003).
23. C. F. Macrae, I. Sovago, J. Appl. Crystallogr., 53, 226 (2019).
24. M. J. Frisch, G. W. Trucks, H. B. Schlegel, et al., Fox, Gaussian 09, Revision A.1, Gaussian, Inc., Wallingford CT (2009).
25. GaussView, Version 5, Roy Dennington, Todd Keith, John Millam, Semichem Inc., Shawnee Mission KS (2009).
26. A. D. Becke, J. Chem. Phys., 98, 5648 (1993).
27. C. Lee, W. Yang, R. G. Parr, Phys. Rev. B, 37, 785 (1988).
28. J. Heyd, G. Scuseria, J. Chem. Phys., 121, 1187 (2004).
29. J. Heyd, G. E. Scuseria, J. Chem. Phys., 120, 7274 (2004).
30. J. Heyd, J. E. Peralta, G. E. Scuseria, R. L. Martin, J. Chem. Phys., 123, 174101 (2005).
31. J. Heyd, G. E. Scuseria, M. Ernzerhof, J. Chem. Phys., 124, 219906 (2006).
32. D. Avcı, S. Bahceli, O. Tamer, Y. Atalay, Can. J. Chem., 93, 1147 (2015).
33. H. Pir Gumus, O. Tamer, D. Avcı, Y. Atalay, J. Phys., 90, 1 (2015).
34. S. Sevvanthi, S. Muthu, S. Aayisha, P. Ramesh, M. Raja, Chem. Data Coll., 30, 100574 (2020).
Review
For citations:
Gümüş H., Tekin N., Kara Y.S. Structural and Spectroscopic Characterization of 3-[4-(Trifluoromethyl)Phenyl]-3a,4,8,8a-Tetrahydro-6H-[1,3]Dioxepino[5,6-d][1,2]Oxazole Compound: an Experimental and Density Functional Theory Study. Zhurnal Prikladnoii Spektroskopii. 2022;89(6):897.
Views: 144
Email this article 